|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
700 Main Street, Cambridge, MA 02139, US
|
|
AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system. Operational since 2020, AXONIS is a seed-stage therapeutics company based in LabCentral, MA, and has assembled a team of world-leading innovators, serial entrepreneurs, successful drug developers, driven scientists and passionate patient advocates.
Adult-onset central nervous system (CNS) disorders are an urgent, unmet, global and growing burden, especially as more people are living longer. Neuron degeneration and excitation/inhibition imbalances are fundamental problems of many debilitating neurological disorders. AXONIS is developing a pipeline of neuron-reviving therapeutics which enable an intrinsic ability of CNS neurons to: (1) resist neurodegeneration, (2) restore excitation/inhibition balance, and (3) regenerate.
|
AXONIS Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used AXONIS Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact AXONIS Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.